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ABSTRACT Glutamate receptors are the predominant
excitatory neurotransmitter receptors in the mammalian brain
and are classified on the basis of their activation by different
agonists. The agonists kainate and a-amino-3-hydroxy-5-
methyl-4-isoxasolepropionic acid define a class of glutamate
receptors termed kainate receptors. We have isolated and
sequenced a human glutamate receptor (GluHI) cDNA and
determined the chromosomal localization of its gene. The DNA
sequence of GIuHI would encode a 907-amino acid protein that
has a 97% identity to one of the rodent kainate receptor
subunits. Many of the changes between the predicted amino
acid sequence of GluHI and the most similar rodent kainate
receptor (GIuRI) occur in a region of the protein encoded in
rodents by an alternatively spliced exon. The extreme conser-
vation between the human and rat kainate receptor subunits
suggests that a similar gene family will encode human kainate
receptors. The GIuHI mRNA is widely expressed in human
brain. The human gene encoding the GluHI subunit is located
at 5q33. While the GIuHI gene is not located near a chromo-
somal region associated with any human neurogenetic disor-
ders, the homologous region on mouse chromosome 11 contains
the sites of five neurologic mutations.
Glutamate receptors are the predominant excitatory neuro-
transmitter receptor in the mammalian brain and are acti-
vated in a variety of normal neurophysiological processes (1,
2). The classification of glutamate receptors has been based
on their activation by different pharmacological agonists.
Glutamate receptors have therefore been named according to
their respective agonists, the N-methyl-D-aspartate
(NMDA), quisqualic acid (QUIS), kainate (KA), and 2-ami-
no-4-phosphonobutyrate (AP4) receptors (1). Quisqualate
receptors are also activated by the more selective agonist
a-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid
(AMPA).
The molecular cloning of cDNA for a rodent glutamate
receptor (GIuRI) has led to significant advances in our
understanding of KA- and AMPA-gated glutamate receptors
(3). Four additional types of KA receptor subunit cDNAs
have been isolated from rat with various degrees of nucleo-
tide and amino acid sequence identity to GluRI (3-7). Com-
parison of these sequences suggests that glutamate receptors
sensitive to KA and AMPA are encoded by a family ofclosely
related genes. The coexpression of different complementary
RNA (cRNA) transcripts derived from these cDNAs in
Xenopus oocytes has shown that (i) the respective protein
products can interact to form heteromeric receptors; (ii) the
agonists KA and AMPA can activate the same receptor or
receptor subunit combinations; and (ifi) different combina-
tions of receptor subunits display distinct electrical proper-
ties (3-7). The extended family of related KA/AMPA recep-
tor genes in rats suggests that, if these genes are conserved,
multiple receptor subunit genes will also be used to generate
diversity in human KA receptors.
Human glutamate receptors are ofmedical interest because
of their postulated role in the mediation ofexcitation-induced
neuronal cell death, particularly in stroke and inherited
neurodegenerative disorders (8, 9). To determine ifglutamate
receptors are involved in any inherited neurodegenerative
disorders will require the molecular cloning of human gluta-
mate receptor genes and the determination of any linkage of
these genes to inherited neurodegenerative disorders. To
begin this analysis, we have characterized the cDNA for a
human glutamate receptor subunit gene¶ and determined its
chromosomal localization.
MATERIALS AND METHODS
Isolation of Human cDNAs. Poly(A)+ RNA was isolated
from the brains of Wistar rats. One microgram of rat brain
poly(A)+ RNA was transcribed with avian myeloblastosis
virus reverse transcriptase. A pair of 34-residue oligonucle-
otides with a 10-nucleotide (nt) Xho I site on a 5' end were
synthesized:
KAl 5'-GACTCGAGTCGACCGGGGCCTGTC-
AGTCGTGCAG-3'
and
KA2 5'-GACTCGAGTCACAGTCCCCAGCATT-
CCCCCGGCG-3'.
The last 24 nucleotides of KA1 correspond to nucleotides
400-424 and the last 24 nucleotides ofKA2 correspond to the
complement of nucleotides 894-918 of the published se-
quence of GluRI (5). The oligonucleotides KA1 and KA2
were used as primers in a polymerase chain reaction (PCR)
with the rat brain cDNA. This PCR product was gel purified
and random primed (10). About 400,000 recombinants of a
human brainstem-cerebellum AGT11 cDNA library (11) were
screened with this radiolabeled probe under reduced strin-
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gency conditions [40% (vol/vol) formamide/5 x SSPE at
370C (lx SSPE is 180 mM NaCl/10 mM sodium phosphate,
pH 7.4/1 mM EDTA)]. Nylon filters were washed to a final
stringency of 0.5X SSPE at 500C.
Nucleotide Sequence Determination and Analysis of Pre-
dicted Amino Acid Sequence. Nucleotide sequence was de-
termined by the use of the chain-termination method. Se-
quence analysis and comparisons were performed with the
Wisconsin General Computing Sequence Analysis Package
and version 66 of the GenBank and European Molecular
Biology Laboratory data banks (12, 13). Amino acid align-
ments were performed with the CLUSTAL program, utilizing
gaps of up to 10 amino acids and a gap penalty of 10 (14). A
phylogenetic comparison was performed with the PAUP pro-
gram (15).
Genomic Blotting. Genomic blots of human DNA cleaved
with the restriction enzymes BamHI, EcoRI, HindIll, and
Xba I were prepared as described (16). A genomic blot
utilizing field inversion electrophoresis on human genomic
DNA cleaved with Sfi I and Sal I was generously provided by
Kai Wang. All blots were hybridized at high stringency (50%o
formamide/4x SSPE at 420C) and washed to a final strin-
gency of 0.2x SSPE at 600C.
RNA Blots and Ribonuclease Protection Assays. Northern
blots were performed with S gg of poly(A)+ RNA isolated
from postmortem human brain and hybridized and washed
under the conditions described above for genomic blots.
Ribonuclease protection assays (17) were performed with 5
,ug of total RNA, and protected fragments were electropho-
resed on denaturing 5% polyacrylamide gels and examined by
autoradiography. The antisense cRNA probe used to detect
mRNA for the human glutamate receptor GluHI was derived
from a 500-base-pair (bp) Pst I-EcoRI fragment from the 5'
end ofGluHI cDNA cloned in pBluescript KS+ (Stratagene).
The antisense cRNA control was derived from a 300-bp
fragment of mouse ,B-actin. Both probes were hybridized in
the same reaction and digested, and they gave protected
fragments of 475 bp for the GluHI cRNA and multiple bands
including the 220-bp one for the f-actin probe.
Isolation of Human Genomic Clones. Two genome equiva-
lents of a human cosmid library were screened with random-
primed probe at high stringency by colony hybridization.
Chromosomal Preparation. Prometaphase chromosomes
were prepared from peripheral blood lymphocytes by using
the bromodeoxyuridine synchronization method (18).
In Situ Hybridization. Cosmid DNAs were labeled with
biotin-11-dUTP (Sigma) by using nick translation. Preanneal-
ing the probe and in situ hybridization were performed as
described by Lichter et al. (19) with some modification.
To generate clear reverse bands (20), chromosome prep-
arations were then counterstained with chromomycin A3
followed by distamycin (J.K., unpublished method), a mod-
ification of the procedure of Magenis et al. (21). To simul-
taneously see both the fluorescein isothiocyanate (FITC)
signal and the banding pattern, Zeiss filter set 05 was utilized
and the resulting image was photographed with Kodak tech-
nical pan film.
RESULTS
Isolation and Characterization of the Human KA Receptor
cDNA. To isolate a human glutamate receptor cDNA, we
screened, under reduced stringency conditions, a human
brain cDNA library with a rodent probe. The probe was
derived by PCR amplification of reverse-transcribed rat brain
RNA by using oligonucleotide primers based on the sequence
of the rat KA/AMPA-sensitive receptor GluRI. This screen
yielded eight positive A clones. One clone, designated GluHI,
contained a 3.1-kilobase (kb) insert, and the sequence of this
clone was determined by chain termination methods on both
strands. The predicted protein encoded by the GluHI cDNA
is 907 amino acids (Fig. 1) with molecular weight of 100,000.
The predicted amino acid sequence of GluHI has 97% iden-
tity with the rodent GluRI (3). There is a potential signal
peptide after the first ATG ofthe longest open reading frame.
GluHI Identifies a Widely Expressed mRNA. KA receptors
have been shown to be widely expressed in rodent brain (4).
GluHI identified a single 5.5-kb message on RNA blots of
poly(A)+ RNA isolated from human brainstem and cerebel-
lum (Fig. 2A). Ribonuclease protection assays on total RNA
indicate that GluHI is widely expressed in human brain. The
relative order of abundance of message identified by GluHI
antisense cRNA is cerebellum > temporal cortex - frontal
cortex = hypothalamus > spinal cord (Fig. 2B). The GluHI
message is not identified in human muscle (Fig. 2B, lane 6).
GluHI Identifies a Single Gene. Genomic blots of human
DNA probed with GluHI cDNA demonstrate a large number
of fragments under high-stringency conditions (data not
shown). These restriction endonuclease fragments minimally
encompass 50-60 kb. When GluHI is used as a probe on
human genomic DNA cleaved with Sfi I and Sal I, only a
single Sal I band is identified: 250 kb (data not shown). These
results suggest that the human KA receptor subunit GluHI is
encoded by a gene between 50 and 250 kb in size. Since the
GluHI cDNA is 2.5 kb smaller than the message identified in
human brain RNA, it probably would not identify all of the
genomic fragments encoding the 3' region of the GluHI
mRNA.
Genomic Cloning of Human KA Receptor Subunit. The
human cDNA (GluHI) was utilized as a probe to screen a
human cosmid library under stringent conditions. Three
cosmids were isolated from this screen, designated KAG1.1,
KAG2.1, and KAG3.1. Restriction digests of these cosmids
demonstrated that they contained inserts between 32 and 35
kb in length. On the basis of the fragment sizes observed after
cleavage with different restriction endonucleases, each
cosmid appears to be an independent clone but to have
overlapping fragments.
The Gene Encoding GluHI Is Located at 5q33. To determine
the genomic locations of the three cosmids (KAG1.1,
KAG2.1, and KAG3.1), fluorescence in situ hybridization
was utilized. Each of the three cosmids independently iden-
tified a single site of hybridization on chromosomeS band q33
in high-quality metaphase preparations. Clean signals were
noted on both chromatids of both chromosomes 5 in 50% of
metaphase cells, on three chromatids in 40%, and on two
chromatids in 10%o of cells. Over 300 cells were evaluated in
five independent experiments using KAG3.1. No other sites
of hybridization were noted on both chromatids of any other
chromosome band (Fig. 3). The precise band location was
identified by using chromosomes of about 650 bands and
employing reverse banding with chromycin A3 and distamy-
cin.
Experiments utilizing the simultaneous hybridization of
KAG3.1 and KAG2.1 revealed occasional closely spaced
double signals arranged diagonally on each of the single
chromatids. Although this may indicate the presence of two
closely spaced genes, it may also represent two independent
signals emanating from the ends of a single gene or an artifact
ofunknown significance occasionally seen with single cosmid
hybridization. These possibilities can be resolved by using
two-color fluorescence hybridization of interphase material.
DISCUSSION
The degree of identity and similarity (allowing for conserva-
tive amino acid substitutions) between the human cDNA
product and the five rat KA receptor clones and chicken and
frog KA-binding proteins is represented in Fig. 4. Compar-
ison of the nucleotide sequences of the five rodent cDNAs
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Signal Peptide
GLUH1 MOHI FAFFCTGFLGAVVGANFPNNIOIGGLFPNOOSO --- EHAAFRFALSOLTEPP-. KLLPOIDI VNISDSFEMTYRFCSOFSKGVYAI FGFYERRTVNMLTSFCGALHVCFITPSF
GLURI MPYIFAFFCTGFLGAVVGANFPNNIO L PNOQSO ---- HA RFALSOLTEPP------ K LPOIDIVNISDT EMTYRF S FSKG Y I FYERRTVNMLT FCGA HVCFITPSF
GLURK-2 MOKIMHISVLLSPVLWGLIFGVSSNSIO L PRGADQ---- YS RVGMVOFSTSE----- fR TPHIONLEVANS AVTNAF S FSRG Y I FYOKKSVNTIT FCGT HVSFITPSF
GLURC MGOSVLRAVFFLVLGLLGHSHGGFPNTIS L MRNTVO---- HS RFAVOLYNTNQNTTEKPFH NYHVDHLDSSNS SVTNAF S FSRG Y I FYDOMSMHTLT FCGA HTSFVTPSF
GLURD MRIICROIVLLFSGFWGLAMGAFPSSVO L IRNTDO ---- YT RLAIFLHNTSPNASEAPFN VPHVDNIETANS AVTNAF S YSRG F I LYDKRSVHTLT FCSA HISLITPSF
GLURS MERSTVLIQPGLWTRDTSWTLLYFLCYILPOTSPOVLR I ETVEHEPVNV EL KFAVTSINRNRTLMPNT-T TYDIORINLFOS EASRRA 0 LALC A L PSHSSSVSAVO ICNA EVPHIOTRW
GLUH1 .. PVDTSNOFVLOL RP ELOD ... AL IS I IDHY KWOKFVY I YDADRGL SVLOKVLDTAAEKNWQVTAVN ILTTTE E - - -- GY RML FODL EKKKE RLVVVDC ES ERLNA ILGO I IKL EKNG IGYHY ILANLGFMODIO
GLUR1 .-- PVDTSNO VLOLR ELOE--- LISIIDH K OTFVYI DADR LSV RVLDTAAEKNWOVTAVHILTTTEE--.-GYRMLFODLEKKK RLVVV ESERLNA LG IVKLEKNGIG ILAN GFMDID
GLURK-2 -- PTDGTHP VIOMR DLKG- - LLSLIEY 0 DKFAYL DSOR LST AVLDSAAEKKWOVTAINVGNINNDKKDETYRSLFODLELKK RRVIL ERDKVHD VD VITIGKHVKG IIAN GFTDGD
GLURC --PTDADVO VIOMR ALKG--. ILSLLSY K EKFVYL DTER FSV AIMEAAVOMMWOVTARSVGNIKD --VOEFRRIIEEMDRRO KRYLI EVERINT LE VVILGKHSRG MLAN GFTDIL
GLURD -.- PTEGESO VLOLR SLRG--- LLSLLDH E NCFVFL DTDR YSI AIMEKAGONGWHVSAICVENFND .. V-SYROLLEELDRRO KKFVI EIERLON LE IVSVGKHVKG H1AN GFKDIS
GLUR5 KHPSVDSRDL YINLY DYAAISR VLDLVLY N KTVTVV EDST LIR ELIKAPSRYNIKIKIROLPPANKDAK---. PLLKEMKKSK FYVIF SHETAAE LK ILFMGMMTEY FFTT DLFALD
GLUH1 LNKFKESGANVTGFOLVNYTDTI PAKIMDOWKNSDARDHTRVDWK - --- RPKYTSALTYDGVKVMAEAFOSLRRORI DISRRGNAGDCLANPAVPWGOGI DIORALOOVRFEGLTGNVOFNEK-GRRTNYTLHVI E
GLURl NKFKES R VT OLVNYTDTIPARIMOO RTSDSRDHTRVDWK ----RPKYTS TY GVKVMAEAFOSL RORIDI RRGNAGD LANPAV GO IDIORALOOVRFE LT NVO NEK- R TNYTLHVIE
GLURK-2 LKIOFG A VS DIVDVDDSLVSKFIER STLEEKEYPGAHTA- ---TIKYTS TY AVOVMTEAFRNL KORIEI RRGNAGD LANPAV GO VEIERALKOVOVE LS NIK DON- K INYTINIME
GLURC ERVMHG A IT OIVNNENPMVOOFIOR VRLDEREFPEAKNA- --- PLKYTS TH AILVIAEAFRYL RORVDV RRGSAGD LANPAV SO IDIERALKMVDVO MT NID DTY- R TNYTIDVYE
GLURD ERFIHG A VT OLVDFNTPMVTKLMDR KKLDOREYPGSETP -- P-KYTS TY GVLVMAETFRSL ROKIDI RRGNAGD LANPAA GO IDMERTLKOVRIO LT NVO DHY- R VNYTMDVFE
GLUR5 ELYRYS V MT RLLNIDNPHVSSIIEK SMERLOAPPRPETGLLDGMMTTEA MY AVYMVAIASH-- ASOLTV SL--- - --HRHK RL PRFMNLIKEARWD LT RIT NKTD L KOFDLDIIS
GLUH1 MKHDGI............... RKIGYWNEDOKFVPAATDAOAGGD-NSSVONRTYIVTTILEDPYVMLKKNANOFEGNDRYEGYCVELAAEIAKHVGYSYRLEIVSDGKYGARDPOTKAWNGMVGELVYGRAOVAV
GLURl M HD I .------------R I Y HEDDKFVPAATDAOAGGD-NSSVC R YI L D LK NANOFE DRY G VE AA IAKHVGYS RLEI S RDPDTKA G VYGR DV V
GLURK-2 L TN P .- ---R I Y SEVDKMVVTLTELPSGND-TSGLE K VV L S MK NHEMLE ERY G VD AA IAKHCGFK KLTI G RDADTKI G VYGK DI I
GLURC M VS S.-...- .- R A Y NEYERFVPFSDOO-ISND-SSSSE R IV L S YK HHEOLE ERY G VD AY IAKHVRIK KLSI G RDPETKI G VYGR DI V
GLURD L ST P ..-----.----R V Y NDMDKLVLIODMPTLGND-TAAIE R VV M S YK NHEMFE DKY G VD AS IAKHIGIK KIAI P RDADTKI G VYGK El I
GLUR5 L EE TEKASGEVSKHLYKVWK I I NSNSGLNMTDGNRDRSMNITDSLA R LI L E YR SDKPLY DRF C LO LK LSHILGFL DVKL P OH-DKGE K IDHR DL V
Tml Tm2-Tm3
GLUHI APLTITLVREEVIDFSKPFMSLGISIMIKKPOKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHSEEFEEGRD- -OTTSDOSNEFGI FNSLWFSLGAFMODGCOISPRSLSGRIVGGVWWFFTL
GLUR1 L E MS MIK QKSK 0 AYE CIVF YI V LVS S HSEEFEEGRD--DTTSDOS E GIF L SL FMO COIS RS G V
GLURK-2 L E MS MIK DKSK 0 AYE CIVF YI V LVS S HTEEFEDGRETD--SSEST E GIF L SL FMR CDIS RS G V
GLURC L E MS MIK DKSK 0 AYE CIVF YI V LVS S HLEDNNEEPRDPQSPPDPP E GIF L SL FMO COIS RS G V
GLURD L E MS MIK QKSK D AYE CIVF YI V LVS S HTEEPEDGKEGP--SDDPP E GIF L SL FMD COIS RS G V
GLUR5 Y K NT LYR NGTN N SPO YVLL CL C VIA T Y-----NPHPCNPOSDVVE N TLL F GV LNC SELM KA T I
rGLUH1 IIISSYTANLAAFLTVERMVSPIESAEOLAKOTEIAYGTLEAGSTKEFFRRSKIAVFEKMWTYMKSAEPSVFVRTTEEGMIRVRKSKGKYAYLLESTMNEYIEQRKPCOTMKVGGNLOSKGYGIATPKGSALRGPV
GLUR1 MV E E A E A TLEA KE RR AVFE M TYMK AEP VFVRTTEE MI RKSKGKY Y L MN IE KP DTMKV NL IA K ALRNPV
GLURK-2 MV E E SK E A TLDS KE RR AVFD M TYMR AEP VFVRTTAE VA RKSKGKY Y L MN IE KP DTMKV NL IA K SLGTPV
GLURC MV E E AK E A TLDS KE RR AVYE M SYMK AEP VFTKTTAD VA RKSKGKF F L MN IE KP DTMKV NL VA K ALGNAV
GLURD MV E E AK E A TLDS KE RR AVYE M TYMR AEP VFTRTTAE VA RKSKGKF F L MN TE KP DTMKV NL VA K SLGNAV
GLUR5 NE 0 0 AK K E AVRD MT KK STYE N AFNS ROO ALVKNSDE ID LTT--DY L M SI VT N- NLTOI LI VG I PYROKI
-At. Exon TM4
GLUH1 NLAVLKLSEOGVLDKLKSKWWYDKGECGSKDSGSJDKTSALSLSNVAGVFYILIGGLGLAMLVALIEFCYKSRSESKRMKGFCLIPOOSINEAIRTSTLPRNSAGTAPSSGGSGEHGRVVSHDFPKSMOSIPCMSH
GLURI NL V K N 0 L DKL N YOK E GTGGGD DKT SLS VA V YI IG G AML LI C SESKRMKGFCLIPDDSINEAIRTSTLPRNSGAGASGGGGSGENGRVVSODFPKSMDSIPCMSH
GLURK-2 NL V K S 0 V DKL N YDK E GAKDSG EKT SLS VA V YI VG G AML LI C AEAKRMKVAKNPMNINPSSSQNSDNFATYKEGYNVYGIESVKI
GLURC NL V K N 0 L DKL N YOK E GSGGGD DKT SLS VA V YI VG G AMM LI C AESKRMKLTKNTDNFKPAPATNTONYATYREGYNVYGTESVKI
GLURD NL V K N D L DKL N YDK E GSGGGD DKT SLS VA V YI VG G AML LI C AEAKRMKLTFSEATRNKARLSITGSVGENGRVLTPDCPKAVHTGTAIROSSGLAVIASOLP
GLUR5 TI I 0 0 E K HMM E RGN - P--EED E-A GVE IG I IV AA V SVF IG L KNNDVEOCLSFNAIMEELGISLKNOKKLKKKSRTKGKSSFTSILTCHDRRTDRKETVA
*S*GM L*****
GLUH1 SSGMPLGATGL
GLUR1 SSGMPLGATGL
FIG. 1. Comparison of the amino acid sequence of the human KA receptor subunit cDNA GluHI with rodent KA receptor subunits. The
predicted amino acid sequence of GluHI is shown on the top line. Below are the rat KA receptor subunits in order of their amino acid identity
to GluHI. The alignment was performed by CLUSTAL analysis (14). The most amino-terminal and carboxyl-terminal regions ofthe predicted amino
acid sequence were not aligned. Gaps are indicated by -. Identical amino acids shared by GluHI and the other KA receptors are indicated by
open spaces and an asterisk below the sequences. Transmembrane regions proposed by Keinanen et al. (4) for the rodent KA receptors are
indicated above the similar regions of GluHI by the designation Tm. The alternatively spliced exon (Alt. Exon) found in the "flip" and "flop"
versions of rodent KA receptors is indicated above the similar sequence in GluHI (22). The deduced amino acid sequences are from GluRI (3),
GluR-K2 (5), GluRC, GluRD (4), and GluR5 (7).
suggests that the respective mRNAs are unlikely to be ligand (25). The locations of the proposed transmembrane
generated by the alternative splicing of a single gene. A (Tm) regions predicted by Keinanen et al. (4) for the rodent
phylogenetic comparison (Fig. 4) of the human and rodent glutamate receptors are shown above the identical regions of
KA receptors and chicken (23) and frog (24) KA-binding GluHI in Fig. 1. These same regions are predicted to be
proteins suggests that these genes arose from multiple du- membrane-spanning a-helices by Nakanishi et al. (5) in their
plication events that preceded the divergence of frogs and analysis ofKA receptor cDNAs. Within the GluHI sequence
chickens from mammals. Extrapolating from the diversity of there are seven potential transmembrane regions 20 amino
KA receptors seen in rodents, we expect that a similar acids or greater in length predicted by the hydrophobic
diversity is likely to be found in human KA receptors. We moment analysis of Eisenberg et al. (26). While the location
also expect that this diversity will be generated by a similar of these membrane-spanning regions cannot be predicted
family of genes. with certainty (27), the evolutionary conservation in amino
The proposed structure of ligand-gated channels is based acid sequence in this region among different subunits and
on four or more membrane-spanning a-helices and an extra- between species suggests a strong selection against nonsyn-
cellular amino-terminal region that would interact with the onymous substitutions.
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FIG. 2. Analysis by Northern blot (A) and ribonuclease protec-
tion assay (B) of the expression of GluHI mRNA. (A) Northern blot
of5 jig ofpoly(A)+ RNA from human cerebellum probed with GluHI,
demonstrating a single 5.5-kb message. (B) Ribonuclease protection
assay of the relative level of expression of GluHI mRNA in various
regions of the human central nervous system. The 475-nt band
identifies the probe protected by GluHI mRNA, while the 220-nt
band identifies the relative amount of /3-actin mRNA protected by the
mouse (3-actin probe. Lane 1, frontal cortex; lane 2, temporal cortex;
lane 3, hypothalamus; lane 4, cerebellum; lane 5, spinal cord; lane 6,
muscle. Brain tissue was all from a single adult individual but
represents various amounts of gray and white matter from a gross
dissection. The amount of protected f3-actin probe in lanes 1 and 6 is
clearly lower in this experiment. When the assay was repeated and
equal amounts of protected (-actin probe were seen in these lanes,
the relative abundance of GluHI mRNA in different brain regions
was similar.
Many of the amino acid differences (9 of 25 amino acids)
between GluHI and GluRI are in a single 38-amino acid region
defined by Sommer et al. (22). This region separates the third
and fourth predicted membrane-spanning regions (Tm3 and
Tm4) and is strongly conserved in KA receptors, but it shows
considerable divergence in other ionotropic receptors. In
rodent KA receptors this region is encoded by alternatively
spliced exons. The amino acids encoded by this exon in
rodent KA/AMPA receptors are indicated above the same
region ofGluHI in Fig. 1. The alternative splicing ofthe exons
encoding this region produces KA-sensitive receptor sub-
units with different agonist and desensitization profiles. Som-
FIG. 3. In situ localization of the GluHI gene to human chromo-
somal region 5q33. A human chromosome preparation hybridized
with the cosmid KAG3.1 labeled with biotin-11-dUTP. The two
arrows indicate hybridization to the q33 region of two distinct
chromosomes 5.
GLURC
69/82
GLURD
66/82
FROG KBP
37/62
CHICKEN KBP
35/62
GLUR5
39/60
FIG. 4. Phylogram comparing the degree of relatedness in amino
acid sequence between human GluHI, the rodent KA receptor
subunits, and chicken and frog KA-binding proteins (KBP). The
rodent sequences used for this comparison are those utilized and
cited in Fig. 1. The other deduced amino acid sequences are from
chicken KBP (23) and frog KBP (24). The degree of identity and
similarity between GluHI and the other kainate cDNAs is indicated
in numbers below representing percent identity/percent similarity as
determined by a FASTA comparison (13).
mer et al. (22) have designated these different types of
receptor subunits "flip" and "flop." The human cDNA
encoding GluHI would be considered as the flip counterpart
to the flop version of the rodent clone GluRI (5). The
conservation of the sequences encoding the flip type of
receptor in GluHI suggests that the alternative splicing of
similar exons will be used in human glutamate receptor
genes.
The gene encoding this subunit of the KA receptors is
localized to the q33 region of human chromosome 5 (Fig. 3).
Two other receptor genes have been mapped to this band.
They include the colony-stimulating factor 1 receptor
(CSF1R) and platelet-derived growth factor (3 receptor (PDG-
FRB). These two receptors are within 0.5 kb of each other
and are believed to have arisen by a duplication event, since
they are significantly similar (28). The human y-taminobutyric
acid receptor A subunit (GABAA-R) has also been mapped to
5q34-35 by in situ hybridization (29). Although these genes
all encode cell surface receptors, they do not share any
obvious similarity to GluHI at the amino acid level. Never-
theless, it is certainly possible that the PDGFRB, CSF1R,
and GluHI genes are clustered in this region of human
chromosome 5. However, the assignment ofboth CSF1R and
PDGFRB to 5q33 is less precise than the present assignment
because ofthe lower resolution ofthe techniques used to map
them. Therefore, the GluHI gene may not be as close as
currently indicated to the CSF1R and PDGFRB genes.
Although human chromosome 5 is composed of regions
homologous to five mouse (Mus musculus) chromosomes,
band 5q33 falls in a small region of overlap between homol-
ogous regions that are located on chromosomes 11 (MMU11)
and 18 (MMU18) (30, 31). It is of interest that five neuroge-
netic mutations in the mouse have been mapped to a 5-cen-
timorgan region located in the homologous region onMMU11
(32). These include shaker-2 (sh-2) (33), spasmodic (spd) (34),
vibrator (vb) (35), tipsy (ti) (36), and trembler (Tr) (37). It
would therefore be of interest to use the human cosmids
KAG1.1, KAG2.1, and KAG3.1 to map the gene encoding
the mouse counterpart of this subunit and determine its
segregation with these mouse mutations. The vb mutant is
especially interesting because the expression of this specific
glutamate receptor subunit is highest in the cerebellum, one
of the areas affected in the spinocerebellar degeneration seen
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in vb mutants (35). Although the precise region of homology
is less well mapped on MMUY18, we note a further five
mutations on this chromosome that may be of interest when
map positions of the homologous region are defined (32).
While it has not been shown that excitoxicity is involved in
any human neurological disorder, this concept remains an
attractive hypothesis in explaining disorders characterized
by neuronal degeneration (9). However, there are no inher-
ited human neurological disorders known to map near the
GluHI gene at 5q33. The closest genetically determined
neurological disorder in humans are two forms of spinal
muscular atrophy that map to the 5q11-13 region (38).
Linkage analysis has also shown an association between
anonymous markers on Sq and schizophrenia in several
Icelandic and British families (39). This association was not
seen in other pedigrees (40). However, it would be interesting
to see if the GluHI gene segregates with affected individuals
in the British and Icelandic families. The molecular cloning of
additional human glutamate receptor genes will be necessary
to confirm the conservation of this gene family in humans.
Determining the chromosomal location of each member of
this gene family will establish whether the glutamate receptor
genes map near any genes associated with neurogenetic
disorders in mouse or man.
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